B lymphocyte dysfunctions in HIV infection

被引:131
作者
De Milito, A [1 ]
机构
[1] Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden
关键词
D O I
10.2174/1570162043485068
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HIV establishes a chronic and latent infection that is not eliminated by the host immune defences. The virus induces extensive damage to the immune system, through virus-related and indirect pathogenic mechanisms. Both the cellular and the humoral arms of the immune system are unable to control the infection, which ultimately results in severe exhaustion of several lymphocyte functions and increased susceptibility to secondary and opportunistic infections. A striking pathological feature induced by the persistent viral replication is the aberrant activation of cells of the immune system. Among these cells, B lymphocytes are severely damaged and show signs of phenotypic and functional alterations. In parallel to the polyclonal B cell activation and hypergammaglobulinemia, B cells from patients show impaired reactivity to immunisation and in vitro activation signals. In addition, B lymphocytes from HIV-infected subjects are primed for apoptosis. The role of protective Immoral immunity in the control and clinical progression of HIV infection is still much debated and controversial. The aim of the present review is to discuss the mechanisms involved in the loss of B cell functions during HIV infection. In particular, we discuss the role that T and B cell immune activation plays for B cell polyclonal activation and loss of memory B lymphocytes. The current knowledge on B cell damage is also discussed in the context of anti-HIV therapeutic treatment.
引用
收藏
页码:11 / 21
页数:11
相关论文
共 191 条
  • [1] Generation of plasma cells from peripheral blood memory B cells: Synergistic effect of interleukin-10 and CD27/CD70 interaction
    Agematsu, K
    Nagumo, H
    Oguchi, Y
    Nakazawa, T
    Fukushima, K
    Yasui, K
    Ito, S
    Kobata, T
    Morimoto, C
    Komiyama, A
    [J]. BLOOD, 1998, 91 (01) : 173 - 180
  • [2] B cell subpopulations separated by CD27 and crucial collaboration of CD27(+) B cells and helper T cells in immunoglobulin production
    Agematsu, K
    Nagumo, H
    Yang, FC
    Nakazawa, T
    Fukushima, K
    Ito, S
    Sugita, K
    Mori, T
    Kobata, T
    Morimoto, C
    Komiyama, A
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (08) : 2073 - 2079
  • [3] Evidence for a correlation between antibody-dependent cellular cytotoxicity-mediating Anti-HIV-1 antibodies and prognostic predictors of HIV infection
    Ahmad, R
    Sindhu, STAK
    Toma, E
    Morisset, R
    Vincelette, J
    Menezes, J
    Ahmad, A
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2001, 21 (03) : 227 - 233
  • [4] Longitudinal analysis of human cytomegalovirus glycoprotein B (gB)-specific and neutralizing antibodies in AIDS patients either with or without cytomegalovirus end-organ disease
    Alberola, J
    Tamarit, A
    Cardeñoso, L
    Estellés, F
    Igual, R
    Navarro, D
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2001, 64 (01) : 35 - 41
  • [5] RAPID DEVELOPMENT OF ISOLATE-SPECIFIC NEUTRALIZING ANTIBODIES AFTER PRIMARY HIV-1 INFECTION AND CONSEQUENT EMERGENCE OF VIRUS VARIANTS WHICH RESIST NEUTRALIZATION BY AUTOLOGOUS SERA
    ALBERT, J
    ABRAHAMSSON, B
    NAGY, K
    AURELIUS, E
    GAINES, H
    NYSTROM, G
    FENYO, EM
    [J]. AIDS, 1990, 4 (02) : 107 - 112
  • [6] AMADORI A, 1991, J IMMUNOL, V146, P57
  • [7] AMMANN AJ, 1984, JAMA-J AM MED ASSOC, V251, P1447, DOI 10.1001/jama.251.11.1447
  • [8] ARNEBORN P, 1983, CLIN EXP IMMUNOL, V51, P165
  • [9] AUCOUTURIER P, 1986, CLIN EXP IMMUNOL, V63, P234
  • [10] Mechanisms of HIV-associated lymphocyte apoptosis
    Badley, AD
    Pilon, AA
    Landay, A
    Lynch, DH
    [J]. BLOOD, 2000, 96 (09) : 2951 - 2964